Search

Deborah Crouch

Examiner (ID: 19500, Phone: (571)272-0727 , Office: P/1632 )

Most Active Art Unit
1632
Art Unit(s)
3725, 1819, 1632, 2899, 1804
Total Applications
1439
Issued Applications
694
Pending Applications
237
Abandoned Applications
511

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 914988 [patent_doc_number] => 07326824 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-05 [patent_title] => 'Unactivated ungulate oocytes to produce a transgenic ungulate by nuclear transfer' [patent_app_type] => utility [patent_app_number] => 10/190617 [patent_app_country] => US [patent_app_date] => 2002-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6832 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/326/07326824.pdf [firstpage_image] =>[orig_patent_app_number] => 10190617 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/190617
Unactivated ungulate oocytes to produce a transgenic ungulate by nuclear transfer Jul 8, 2002 Issued
Array ( [id] => 755522 [patent_doc_number] => 07019193 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-03-28 [patent_title] => 'Treatments using transgenic goat produced antithrombin III' [patent_app_type] => utility [patent_app_number] => 10/188658 [patent_app_country] => US [patent_app_date] => 2002-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 6514 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/019/07019193.pdf [firstpage_image] =>[orig_patent_app_number] => 10188658 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/188658
Treatments using transgenic goat produced antithrombin III Jul 1, 2002 Issued
Array ( [id] => 1179368 [patent_doc_number] => 06743966 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-06-01 [patent_title] => 'Production of membrane proteins in the milk of transgenic mammals' [patent_app_type] => B2 [patent_app_number] => 10/185269 [patent_app_country] => US [patent_app_date] => 2002-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 4690 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/743/06743966.pdf [firstpage_image] =>[orig_patent_app_number] => 10185269 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/185269
Production of membrane proteins in the milk of transgenic mammals Jun 26, 2002 Issued
10/180904 SPC7 serine protease gene disruptions, and compositions and methods related thereto Jun 24, 2002 Abandoned
Array ( [id] => 6866542 [patent_doc_number] => 20030192068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-09 [patent_title] => 'Production of recombinant polypeptides by bovine species and transgenic methods' [patent_app_type] => new [patent_app_number] => 10/170221 [patent_app_country] => US [patent_app_date] => 2002-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 31683 [patent_no_of_claims] => 97 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20030192068.pdf [firstpage_image] =>[orig_patent_app_number] => 10170221 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/170221
Production of recombinant polypeptides by bovine species and transgenic methods Jun 10, 2002 Abandoned
Array ( [id] => 6261762 [patent_doc_number] => 20020187931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-12 [patent_title] => 'Modulating cell survival by modulating huntingtin function' [patent_app_type] => new [patent_app_number] => 10/009478 [patent_app_country] => US [patent_app_date] => 2002-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 16895 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20020187931.pdf [firstpage_image] =>[orig_patent_app_number] => 10009478 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/009478
Modulating cell survival by modulating huntingtin function May 30, 2002 Abandoned
Array ( [id] => 7275497 [patent_doc_number] => 20040234948 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Gene transfer into primate embryonic stem cells using vsv-g pseudo type simian immunodeficiency virus vectors' [patent_app_type] => new [patent_app_number] => 10/479912 [patent_app_country] => US [patent_app_date] => 2004-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16230 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20040234948.pdf [firstpage_image] =>[orig_patent_app_number] => 10479912 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/479912
Gene transfer into primate embryonic stem cells using VSV-G pseudotyped simian immunodeficiency virus vectors May 28, 2002 Issued
Array ( [id] => 6745175 [patent_doc_number] => 20030022358 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'Growth of filterable organisms that require non-diffusable media components' [patent_app_type] => new [patent_app_number] => 10/155799 [patent_app_country] => US [patent_app_date] => 2002-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2578 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20030022358.pdf [firstpage_image] =>[orig_patent_app_number] => 10155799 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/155799
Growth of filterable organisms that require non-diffusable media components May 23, 2002 Abandoned
Array ( [id] => 7616993 [patent_doc_number] => 06946448 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-09-20 [patent_title] => 'In utero oral nucleic acid immunization' [patent_app_type] => utility [patent_app_number] => 10/155867 [patent_app_country] => US [patent_app_date] => 2002-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 19791 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/946/06946448.pdf [firstpage_image] =>[orig_patent_app_number] => 10155867 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/155867
In utero oral nucleic acid immunization May 22, 2002 Issued
Array ( [id] => 6688458 [patent_doc_number] => 20030032183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Stem cell differentiation' [patent_app_type] => new [patent_app_number] => 10/156602 [patent_app_country] => US [patent_app_date] => 2002-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4432 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20030032183.pdf [firstpage_image] =>[orig_patent_app_number] => 10156602 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/156602
Stem cell differentiation May 22, 2002 Abandoned
Array ( [id] => 6755313 [patent_doc_number] => 20030003090 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-02 [patent_title] => 'Directed in vitro differentiation of marrow stromal cells into neural cell progenitors' [patent_app_type] => new [patent_app_number] => 10/153972 [patent_app_country] => US [patent_app_date] => 2002-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6227 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20030003090.pdf [firstpage_image] =>[orig_patent_app_number] => 10153972 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/153972
Directed in vitro differentiation of marrow stromal cells into neural cell progenitors May 22, 2002 Abandoned
Array ( [id] => 7616993 [patent_doc_number] => 06946448 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-09-20 [patent_title] => 'In utero oral nucleic acid immunization' [patent_app_type] => utility [patent_app_number] => 10/155867 [patent_app_country] => US [patent_app_date] => 2002-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 19791 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/946/06946448.pdf [firstpage_image] =>[orig_patent_app_number] => 10155867 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/155867
In utero oral nucleic acid immunization May 22, 2002 Issued
Array ( [id] => 6819228 [patent_doc_number] => 20030070186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-10 [patent_title] => 'Method of cloning animals' [patent_app_type] => new [patent_app_number] => 10/155904 [patent_app_country] => US [patent_app_date] => 2002-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 30473 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 37 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20030070186.pdf [firstpage_image] =>[orig_patent_app_number] => 10155904 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/155904
Method of cloning animals May 21, 2002 Abandoned
10/130347 Method for production of porcine clone embryos via somatic cell nuclear transfer May 16, 2002 Abandoned
Array ( [id] => 872485 [patent_doc_number] => 07361684 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-22 [patent_title] => 'Screening of compounds for treatment of atherosclerosis and heart attack' [patent_app_type] => utility [patent_app_number] => 10/147651 [patent_app_country] => US [patent_app_date] => 2002-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11886 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/361/07361684.pdf [firstpage_image] =>[orig_patent_app_number] => 10147651 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/147651
Screening of compounds for treatment of atherosclerosis and heart attack May 15, 2002 Issued
Array ( [id] => 6687924 [patent_doc_number] => 20030031649 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Gene therapy to promote angiogenesis' [patent_app_type] => new [patent_app_number] => 10/136545 [patent_app_country] => US [patent_app_date] => 2002-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10918 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20030031649.pdf [firstpage_image] =>[orig_patent_app_number] => 10136545 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/136545
Gene therapy to promote angiogenesis Apr 30, 2002 Abandoned
Array ( [id] => 6557962 [patent_doc_number] => 20020194635 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Transgenic animals resistant to transmissible spongiform encephalopathies' [patent_app_type] => new [patent_app_number] => 10/109551 [patent_app_country] => US [patent_app_date] => 2002-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16620 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20020194635.pdf [firstpage_image] =>[orig_patent_app_number] => 10109551 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/109551
Transgenic animals resistant to transmissible spongiform encephalopathies Mar 27, 2002 Abandoned
Array ( [id] => 6554604 [patent_doc_number] => 20020164335 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'Compositions and methods for the study and diagnosis of prion diseases' [patent_app_type] => new [patent_app_number] => 10/106574 [patent_app_country] => US [patent_app_date] => 2002-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 9268 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20020164335.pdf [firstpage_image] =>[orig_patent_app_number] => 10106574 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/106574
Compositions and methods for the study and diagnosis of prion diseases Mar 25, 2002 Abandoned
Array ( [id] => 7252579 [patent_doc_number] => 20050074880 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-07 [patent_title] => 'Generation of multipotent central nervous system stem cells' [patent_app_type] => utility [patent_app_number] => 10/473003 [patent_app_country] => US [patent_app_date] => 2002-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 10127 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20050074880.pdf [firstpage_image] =>[orig_patent_app_number] => 10473003 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/473003
Generation of multipotent central nervous system stem cells Mar 22, 2002 Abandoned
Array ( [id] => 6817860 [patent_doc_number] => 20030068818 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-10 [patent_title] => 'Animal tissue with carbohydrate antigens compatible for human transplantation and a carbohydrate determinant selection system for homologous recombination' [patent_app_type] => new [patent_app_number] => 10/105963 [patent_app_country] => US [patent_app_date] => 2002-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 18183 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20030068818.pdf [firstpage_image] =>[orig_patent_app_number] => 10105963 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/105963
Animal tissue with carbohydrate antigens compatible for human transplantation Mar 20, 2002 Issued
Menu